RGD Reference Report - Comparative study of the effects of PACAP in young, aging, and castrated males in a rat model of Parkinson's disease. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Comparative study of the effects of PACAP in young, aging, and castrated males in a rat model of Parkinson's disease.

Authors: Reglodi, D  Tamas, A  Lengvari, I  Toth, G  Szalontay, L  Lubics, A 
Citation: Reglodi D, etal., Ann N Y Acad Sci. 2006 Jul;1070:518-24.
RGD ID: 2325295
Pubmed: PMID:16888218   (View Abstract at PubMed)
DOI: DOI:10.1196/annals.1317.072   (Journal Full-text)

We have previously shown that PACAP ameliorates the neurological symptoms and reduces the dopaminergic cell loss in young male rats, in a 6-hydroxydopamine (6-OHDA)-induced lesion of the substantia nigra, a model of Parkinson's disease. In the present study, we compared the effects of PACAP in young, aging, and castrated males. Our results show that PACAP significantly reduced the dopaminergic cell loss in young and aging males. In castrated males, 6-OHDA did not induce such a severe cell loss, and it was not altered by PACAP. However, PACAP effectively ameliorated behavioral symptoms in all groups, with a degree of recovery depending on age and endocrine status.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
ADCYAP1HumanParkinsonism  ISOAdcyap1 (Rattus norvegicus) RGD 
Adcyap1RatParkinsonism  IDA  RGD 
Adcyap1MouseParkinsonism  ISOAdcyap1 (Rattus norvegicus) RGD 

Objects Annotated

Genes (Rattus norvegicus)
Adcyap1  (adenylate cyclase activating polypeptide 1)

Genes (Mus musculus)
Adcyap1  (adenylate cyclase activating polypeptide 1)

Genes (Homo sapiens)
ADCYAP1  (adenylate cyclase activating polypeptide 1)


Additional Information